冠心病患者血清visfatin水平与氧化应激及颈动脉粥样硬化的关系

摘要
图/表
参考文献(25)
相关文章 (15)

全文: PDF (505 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的研究冠心病患者血清内脏脂肪素（visfatin）水平与氧化应激及颈动脉粥样硬化的关系。方法选择2017年1月～2018年1月厦门大学附属成功医院（以下简称“我院”）收治的冠心病患者80例作为研究组，根据Gensini积分将患者分为轻度动脉硬化组（29例）、中度动脉硬化组（25例）、重度动脉硬化组（26例）。按照性别、年龄、血压、血糖、血脂匹配选择我院同期收治的非冠心病患者80例作为对照组。分别比较两组各项生化指标、血清visfatin、丙二醛（MDA）、超氧化物歧化酶（SOD）水平，分析SOD、MDA、颈动脉粥样硬化严重程度与血清visfatin水平的关系。结果两组血压、血糖、血脂水平差异无统计学意义（P ＞ 0.05）。研究组血清visfatin、MDA显著高于对照组，血清SOD显著低于对照组，差异有统计学意义（P ＜ 0.05）。中度动脉硬化组visfatin、MDA显著高于轻度动脉硬化组，SOD低于轻度动脉硬化组，差异有统计学意义（P ＜ 0.05）。重度动脉硬化组visfatin、MDA显著高于轻度和中度动脉硬化组，SOD显著低于轻度和中度动脉硬化组，差异有统计学意义（P ＜ 0.05）。冠心病患者血清visfatin水平与血清MDA水平、Gensini积分呈正相关（r = 0.587、0.634，P < 0.05），与SOD水平呈负相关（r = -0.609，P ＜ 0.05）。结论冠心病患者血清visfatin水平存在明显高表达，且与氧化应激与颈动脉粥样硬化密切相关。临床工作中可通过对血清visfatin水平进行检测，从而有利于评估患者氧化应激状态与颈动脉粥样硬化严重程度，值得临床推广应用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	钟素1 余研1 苏晓娟2 吴永鑫3

关键词 ：冠心病, 内脏脂肪素, 氧化应激, 颈动脉粥样硬化, 相关性分析

Abstract：Objective To study the relationship between serum visfatin level and oxidative stress and carotid atherosclerosis in patients with coronary heart disease. Methods Eighty patients with coronary heart disease admitted to Success Hospital Affiliated to Xiamen University (“our hospital” for short) from January 2017 to January 2018 were selected as the study group. According to Gensini scores, the patients were divided into mild atherosclerosis group (29 cases), moderate atherosclerosis group (25 cases) and severe atherosclerosis group (26 cases). While matching of sex, age, blood pressure, blood sugar and blood lipid, eighty patients with non-coronary heart disease admitted to our hospital during the same period were selected as the control group. The levels of biochemical indicators, serum visfatin, malondialdehyde (MDA) and superoxide dismutase (SOD) were compared between the two groups, respectively. And the relationship between SOD, MDA and the severity of carotid atherosclerosis and the level of serum visfatin were analyzed. Results There were no statistically significant differences in blood pressure, blood sugar and blood lipid between the two groups (P ＞ 0.05). The serum visfatin and MDA in the study group were significantly higher than those in the control group, while the serum SOD in the study group was significantly lower than that in the control group, and the differences were statistically significant (P ＞ 0.05). Serum visfatin and MDA levels in mild atherosclerosis group were higher than those in moderate atherosclerosis group, while SOD levels were lower than that in mild atherosclerosis group, and the differences were statistically significant (P ＜ 0.05). Serum visfatin and MDA levels in severe atherosclerosis group were statistically higher than those in mild and moderate atherosclerosis group, while SOD levels was lower than that in mild and moderate atherosclerosis group, and the differences were statistically significant (P ＜ 0.05). Serum visfatin levels were positively correlated with serum MDA levels and Gensini score (r = 0.587, 0.634, P < 0.05), while negatively correlated with SOD levels (r = -0.609， P ＜ 0.05). Conclusion The serum visfatin levels in patients with coronary heart disease are significantly higher and closely related to oxidative stress and carotid atherosclerosis. Serum visfatin level can be detected in clinical work, which is helpful to assess oxidative stress and severity of carotid atherosclerosis. It is worthy of clinical application.

Key words： Coronary heart disease Visfatin Oxidative stress Carotid atherosclerosis Correlation analysis

基金资助:福建省自然科学基金项目（2016J01085）。

通讯作者: 余研（1978.4-），女，副主任医师；研究方向：老年医学。

作者简介: 钟素（1989.10-），女，硕士；研究方向：老年医学心血管。

引用本文:

钟素1 余研1 苏晓娟2 吴永鑫3. 冠心病患者血清visfatin水平与氧化应激及颈动脉粥样硬化的关系[J]. 中国医药导报, 2019, 16(29): 68-71.
ZHONG Su1 YU Yan1 SU Xiaojuan2 WU Yongxin3. Relationship between serum visfatin level and oxidative stress and carotid atherosclerosis in patients with coronary heart disease. 中国医药导报, 2019, 16(29): 68-71.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2019/V16/I29/68

[1] Zhang LQ，Van Haandel L，Xiong M，et al. Metabolic and molecular insights into an essential role of nicotinamide phosphoribosyltransferase [J]. Cell Death Dis，2017，8（3）：e2705-e2706.
[2] Fletcher RS，Ratajczak J，Doig CL，et al. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metab-olism in skeletal muscle cells [J]. Mol Metab，2017，6（8）：819-832.
[3] 严建军，刘倩，张贞胜，等.血清内脏脂肪素水平与冠心病患者氧化应激、颈动脉粥样硬化的相关性及通心络胶囊的干预作用[J].实用心脑肺血管病杂志，2018，26（4）：54-57，62.
[4] 李波，付世全，陈青梅，等.血清内脂素水平与药物洗脱支架内再狭窄的相关性研究[J].中国循证心血管医学杂志，2018，19（1）：72-75.
[5] 骆莹莹，姚树桐，王大新，等.氧化应激在动脉粥样硬化发生发展中作用的研究新进展[J].中国介入心脏病学杂志，2013，21（1）：46-50.
[6] Mihos CG，Xydas S，Williams RF，et al. Staged percutaneous coronary intervention followed by minimally invasive mitral valve surgery versus combined coronary artery bypass graft and mitral valve surgery for two-vessel coronaryartery disease and moderate to severe ischemic mitral regurgitation [J]. J Thorac Dis，2017，9（7）：563-568.
[7] 丛辉，储海丹，景蓉蓉，等.冠状动脉粥样硬化性心脏病患者血浆的miR-125b-5p水平与病变程度相关性初探[J].中华检验医学杂志，2017，40（5）：396-399.
[8] Fadaei R，Parvaz E，Emamgholipour S，et al. The mRNA Expression and Circulating Levels of Visfatin and Their Correlation with Coronary Artery Disease Severity and 25-Hydroxyvitamin D [J]. Horm Metab Res，2016，48（4）：269-274.
[9] 吴蓉.慢性肾脏疾病患者内脏脂肪和冠状动脉钙化的关系研究[J].临床和实验医学杂志，2017，16（2）：160-163.
[10] 曹玉康，杨波，孙志军，等.心外膜脂肪体积、尿微量白蛋白/肌酐比值及血清炎症因子水平与冠状动脉病变程度分析[J].中华老年多器官疾病杂志，2018，17（4）：247-251.
[11] 周亮亮，邹莺，杭涛，等.血浆和心外膜脂肪瘦素水平与冠状动脉粥样硬化斑块性质相关性[J].中华实用诊断与治疗杂志，2015，29（9）：858-861.
[12] 孙一帆，刘春明.Visfatin与消化系统肿瘤的关系研究进展[J].检验医学与临床，2016，13（16）：2388-2390.
[13] Poljsak B. NAMPT-Mediated NAD Biosynthesis as the Internal Timing Mechanism：In NAD+ World，Time Is Running in Its Own Way [J]. Rejuvenation Res，2018，21（3）：210-224.
[14] 戴青原，郭涛，刘中梅，等.血清内脏脂肪素浓度变化与急性ST段抬高型心肌梗死的关系[J].中国全科医学，2014，17（28）：3341-3345.
[15] 刘涛，张蓉.幽门螺旋杆菌感染对冠心病患者斑块性质的影响及与炎症反应、氧化应激反应的相关性[J].海南医学院学报，2017，23（24）：3346-3349.
[16] 张守信，孙成铭，杨军，等.脂肪因子基因多态性与冠状动脉粥样硬化的研究进展[J].医学综述，2017，23（12）：2308-2312，2317.
[17] Akbarian N，Zarghami N，Mota A，et al. Correlation Between Circulating Visfatin and Nitric Oxide Metabolites Levels in Patients With Diabetic Nephropathy [J]. Iran J Kidney Dis，2018，12（3）：163-168.
[18] 韦彩雯，李志华，宋蕾，等.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者炎症反应、氧化应激、血管内皮功能及心肌功能的影响[J].海南医学院学报，2017， 23（21）：2917-2920.
[19] 刘琦，杨志勇，陈雄辉，等.依达拉奉联合康复治疗对脑梗死患者神经营养状态、氧化应激损伤调节作用分析[J].现代医院，2018，18（8）：1194-1197.
[20] 胡平.高胆固醇血症患者血清Hcy、MDA、SOD水平及血管内皮功能变化的临床意义[J].中外医学研究，2018， 16（23）：48-49.
[21] 王庆丽，卢颖，赵慧颖，等.冠心病患者血清visfatin、A-FABP、IL-6水平与冠状动脉粥样硬化的相关性研究[J].中国循证心血管医学杂志，2016，8（7）：865-867.
[22] 徐彦秋，李力兵.丙泊酚对离体大鼠心脏代谢性酸中毒的影响[J].医学综述，2017，23（19）：3927-3930，3937.
[23] 魏爱婷.冠心病患者血清同型半胱氨酸与丙二醛、超氧化物歧化酶的相关性分析[J].现代诊断与治疗，2017， 28（18）：3469-3470.
[24] 杨增强，蔡兰兰.丹参酮ⅡA磺酸钠注射液对急性心肌梗死患者心肌酶学及心脏泵血功能的影响[J].国际中医中药杂志，2017，39（7）：587-591.
[25] Naz S，Sandhu QS，Akhtar A，et al. Serum Levels of Visfatin and Interleukin-6 in Non-Obese Versus Obese Men with Coronary Artery Disease [J]. J Coll Physicians Surg Pak，2017，27（2）：71-74.